8-K: Tivic Health Faces Nasdaq Delisting Warning

Tivic Health Systems, Inc. received a Nasdaq notification for failing to meet the minimum bid price requirement, initiating a 180-day compliance period.

Summary

• Tivic Health Systems, Inc. (the Company) received a notification from Nasdaq on March 19, 2026, regarding non-compliance with the minimum bid price requirement.
• The Company's common stock closing bid price was below $1.00 per share for at least 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
• This notification does not immediately affect the listing of the Company's common stock on The Nasdaq Capital Market.
• Tivic Health has 180 calendar days, until September 15, 2026, to regain compliance.
• Compliance can be regained if the closing bid price of the common stock closes at or above $1.00 per share for a minimum of 10 consecutive business days.
• If compliance is not regained by September 15, 2026, Nasdaq may grant a second 180-day grace period if the Company meets other listing requirements and notifies Nasdaq of its intent to cure the deficiency.
• The Company intends to actively monitor its stock price and consider options to resolve the deficiency.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a significantly negative development, as a delisting notice from Nasdaq indicates severe underperformance and poses a material risk to the company's ability to access capital markets and maintain investor visibility.

Negatives

• The Company is not in compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
• The common stock's closing bid price has been below $1.00 for at least 30 consecutive business days.

Risks

• There is no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during the initial 180-day compliance period.
• The Company may not secure a second 180-day period to regain compliance.
• The Company may fail to maintain compliance with other Nasdaq listing requirements.
• Failure to regain compliance could lead to the delisting of the Company's common stock from The Nasdaq Capital Market.

Future Outlook

The Company intends to actively monitor its common stock's closing bid price and will consider available options to resolve the deficiency and regain compliance with the Nasdaq Minimum Bid Price Requirement. There is no assurance of regaining compliance or securing extensions.

Management Comments

• "The Company intends to continue actively monitoring the closing bid price for the Companys common stock between now and September 15, 2026, and will consider available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement."

Industry Context

StockSavvy.ai notes that receiving a delisting notice for failing to meet the minimum bid price requirement is a common challenge for smaller or struggling public companies, particularly in volatile market conditions. Such notices often signal underlying operational or financial difficulties, or a lack of investor confidence, which can further depress share prices. Companies in the health systems sector, especially those with early-stage products or limited revenue, can be particularly susceptible to these pressures.

Comparison to Industry Standards

• The Nasdaq minimum bid price requirement of $1.00 is a standard threshold for continued listing across all companies on the Nasdaq Capital Market. Many companies, particularly those in emerging or highly competitive sectors, face similar challenges.
• For example, other small-cap biotech or medical device companies have faced similar delisting notices, often leading to reverse stock splits to artificially boost share price, such as Biocept, Inc. (BIOC) or Avinger, Inc. (AVGR) in previous years, to maintain their listing status.
• The 180-day compliance period is standard for Nasdaq, offering a window for companies to implement strategies like reverse stock splits, business development announcements, or capital raises to improve investor sentiment and stock price.

Stakeholder Impact

• Shareholders face potential loss of liquidity and investment value if the stock is delisted, as trading on over-the-counter markets typically has lower volume and wider bid-ask spreads.
• The Company's ability to raise capital may be negatively impacted, as institutional investors often have mandates against investing in non-Nasdaq listed securities.
• Employee morale and retention could be affected by the uncertainty surrounding the Company's listing status and future prospects.

Next Steps

• Tivic Health Systems, Inc. must achieve a closing bid price of $1.00 or more for at least 10 consecutive business days by September 15, 2026, to regain compliance.
• If compliance is not regained, the Company may seek a second 180-day grace period, provided it meets other listing requirements and notifies Nasdaq of its intent to cure.
• The Company will continue to actively monitor its stock price and evaluate options to resolve the deficiency.

Key Dates

Recommendation

The delisting notice from Nasdaq for failing to meet the minimum bid price requirement is a severe negative indicator. While the company has a compliance period, the underlying issues causing the low stock price are likely significant. The risk of delisting, reduced liquidity, and potential inability to raise capital makes this a high-risk investment with substantial downside potential. Seasoned investors would likely divest to avoid further capital erosion and seek more stable opportunities.

Keywords

Tivic Health Systems, TIVC, Nasdaq, Delisting, Minimum Bid Price, Compliance, Stock Market, SEC Filing, 8-K